CLASSICAL 91 ONE:
Classical Music with Will Griffin
Brentwood-based BioMimetic has filed yet another round of paperwork in hopes of gaining federal approval for its bone graft therapy, called Augmentin.
The studies, tests, and research are done. Now, Franklin-based Biomimetic Therapeutics is ready to ask for FDA approval of its only product.